Target intelligence / Profile preview

Transcription elongation factor A2 (TCEA2)

Target
TCEA2
Molecular classification
Transcription factor
01

Overview

Transcription elongation factor A2 is a nuclear protein classified as an SII class transcription elongation factor, necessary for efficient elongation of RNA polymerase II past template-encoded arresting sites. It facilitates the release of RNA polymerase II ternary complexes from transcriptional arrest, frequently through cleavage of the nascent transcript, allowing resumption of elongation from a new 3’-terminus. TCEA2 interacts with general transcription factor IIB and is primarily expressed in testis tissue, with two transcript variants encoding different isoforms[1][2][3][6]. There is no evidence that TCEA2 acts as a direct therapeutic target or interacts with drugs[1][6].

Other names
TCEA2TFIISTranscription elongation factor A protein 2Transcription elongation factor S-II protein 2Testis-specific S-IITranscription elongation factor TFIIS.lTranscription elongation factor TFIIS.1Transcription elongation factor A (SII)
02

Biological functions

Regulation of transcription by RNA polymerase IITranscription elongationNucleic acid binding
03

Disease associations

Amed syndrome (Digenic)UV-sensitive syndrome

Beyond the preview

Go deeper on Transcription elongation factor A2 (TCEA2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transcription elongation factor A2 (TCEA2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call